WARN Act

Business

Take-Two Blows Past Forecasts, Raises Outlook on Strength of GTA, NBA 2K, and Mobile Surge

The video game giant reported a blockbuster third quarter, with net bookings of $1.76 billion significantly exceeding guidance. Strong performance across its core franchises and a resurgent mobile division have prompted the company to raise its full-year forecast, setting the stage for a pivotal 2027 headlined by the launch of Grand Theft Auto VI.

Feb 4, 2026

Business

Transcat Posts Robust Q3 Growth on Services Strength and Rental Mix Shift

Transcat (TRNS) reported a 26% surge in Q3 fiscal 2026 revenue, driven by strong performance in both its service and distribution segments. While strategic acquisitions and a favorable shift toward higher-margin instrument rentals boosted results, the company posted a net loss due to one-time charges and amortization costs.

Feb 4, 2026

Business

Array Digital Infrastructure: Unlocking Hidden Value Through Asset Monetization

Following the sale of its wireless business, Array Digital Infrastructure (AD) is poised to deliver significant shareholder returns through a series of planned asset sales and strategic consolidation, presenting a compelling value proposition in the telecom infrastructure space.

Feb 4, 2026

Business

Beyond Coal: Peabody Energy (BTU) Bets on Critical Minerals and AI Power Demand to Fuel Growth

Peabody Energy, the U.S. coal giant, is drawing investor attention not just for its core business but for a multi-pronged growth strategy. Analysts point to undervalued coal assets, a burgeoning critical minerals portfolio, and a cyclical demand boost from AI data centers as potential catalysts.

Feb 4, 2026

Business

CarGurus Stock Poised for Rebound as Used Car Market Thaws

After navigating past strategic missteps, online automotive marketplace CarGurus (CARG) is emerging as a leaner, more focused business. With a dominant market position, pricing power, and a cyclical recovery in the used car sector on the horizon, analysts see significant upside potential for the stock.

Feb 4, 2026

Business

Progress Software Faces Headwinds: Debt, Acquisitions Cloud Growth Outlook

A critical analysis of Progress Software Corporation (PRGS) highlights concerns over its leveraged balance sheet, reliance on acquisitions for growth, and weakening core operational metrics, suggesting potential near-term challenges for investors.

Feb 4, 2026

Business

Post Holdings: A Deep-Value Play in Consumer Staples as Cash Flow Inflection Nears

Amid market skepticism toward mid-cap consumer staples, Post Holdings (POST) presents a compelling contrarian case. With shares trading near historical valuation lows and a management team renowned for shrewd capital allocation, analysts point to a looming free cash flow surge and aggressive buybacks as potential catalysts for a significant rerating.

Feb 4, 2026

US

Search Ends in Tragedy: Coast Guard Names Seven Crew Lost in Gloucester Fishing Vessel Sinking

The U.S. Coast Guard has ended its search and identified the seven crew members presumed dead after the commercial fishing vessel 'Lily Jean' sank off Cape Ann, Massachusetts. A formal investigation into the cause of the disaster is now underway.

Feb 4, 2026

Business

Chemed Corporation: A Deep-Value Play as Hospice Unit Faces Temporary Headwinds

Shares of Chemed Corporation (NYSE: CHE), the unique parent of VITAS Healthcare and Roto-Rooter, have fallen roughly one-third from recent highs. A detailed analysis suggests the sell-off, driven by temporary issues at its hospice segment, may have created a compelling valuation opportunity for patient investors.

Feb 4, 2026

Business

SiTime Shares in Focus as Analysts Boost Price Targets on AI-Driven Transformation

SiTime Corporation (SITM) is gaining renewed attention on Wall Street, with UBS and Barclays raising their price targets significantly. Analysts point to the company's strategic pivot towards AI-focused timing solutions as a key driver for improved financial prospects.

Feb 4, 2026

Business

Analysts Bullish on Krystal Biotech as Vyjuvek Momentum Fuels Major Price Target Hikes

Goldman Sachs, Clear Street, and Bank of America have all significantly raised their price targets for Krystal Biotech (KRYS), citing strong growth from its gene therapy Vyjuvek and a promising pipeline targeting ophthalmic and respiratory diseases.

Feb 4, 2026

Business

AMD's MI450 AI Accelerator Poised to Drive Growth as Analysts Bullish on 2026 Outlook

Advanced Micro Devices (AMD) garners a reiterated Buy rating and $300 price target from Susquehanna, with strong data center demand and the upcoming MI450 AI accelerator seen as key growth drivers for the semiconductor giant.

Feb 4, 2026

Business

Analysts Revise Argenx Revenue Forecasts Upward, Signaling Stronger Growth Trajectory

Recent analyst reports from Wells Fargo and H.C. Wainwright suggest consensus revenue estimates for biotech firm Argenx SE may be too conservative, with key drug Vyvgart poised to outperform expectations through 2030.

Feb 4, 2026

Business

Mobileye Maintains Momentum: Analysts See Significant Upside After Strong 2025 Results

Following robust year-end financials and guidance, analysts reaffirm bullish stance on Mobileye Global (MBLY), with Tigress Financial highlighting a potential 178% upside. The autonomous driving tech firm posted double-digit growth in revenue and cash flow.

Feb 4, 2026

Business

Legence Corp. (LGN): Poised for Growth as Data Center Boom Fuels Undervalued Infrastructure Play

Legence Corp., a critical building systems specialist, is emerging as a key beneficiary of the explosive data center market. With Blackstone's backing and trading at a discount to peers, analysts see significant upside potential despite its post-IPO obscurity.

Feb 4, 2026

Business

Primo Water Corporation: A Deep Dive into the Bull Case After the BlueTriton Merger

Primo Water Corporation (PRMB), now North America's leading pure-play water platform following its 2024 merger, presents a compelling investment thesis. Despite a sharp stock decline due to integration challenges, analysts argue the market has overlooked its fundamental strengths, scale advantages, and a clear path to recovery under new leadership.

Feb 4, 2026

Business

Warby Parker's Bullish Outlook: Navigating Consumer Softness with Resilience and Innovation

Amid a challenging retail environment, eyewear disruptor Warby Parker (WRBY) is demonstrating notable resilience. Supported by its focus on higher-income demographics, strategic insurance partnerships, and a promising pipeline of tech-enabled products, the company is positioning for a potential margin inflection and sustained growth.

Feb 4, 2026

Business

Cytokinetics' Heart Drug Aficamten Nears FDA Verdict, Fueling Optimism for $4 Billion Market

With a key FDA decision looming for its lead cardiac drug Aficamten, Cytokinetics stands at a pivotal moment. Analysts see blockbuster potential in treating a debilitating heart condition, positioning the biotech for a potential commercial breakthrough.

Feb 4, 2026

Business

Figure Technology Solutions: Can Blockchain Innovation Justify Its Lofty Valuation?

Fintech firm Figure Technology Solutions (FIGR) is drawing investor attention with its blockchain-powered platform for loan origination and digital assets. While its growth metrics and partner adoption are strong, its high P/E ratio raises questions about its long-term potential in a competitive market.

Feb 4, 2026

Business

National Storage Affiliates Trust: Poised for a Rebound as Self-Storage Sector Dynamics Shift

Amid a cyclical downturn, National Storage Affiliates Trust (NSA) presents a compelling investment case. With housing turnover expected to recover and new supply constrained, this REIT's deep valuation discount and Sunbelt-heavy portfolio could fuel significant upside as industry fundamentals improve.

Feb 4, 2026